DK0772450T3 - Fremgangsmåder til behandling af blødningsforstyrelser - Google Patents

Fremgangsmåder til behandling af blødningsforstyrelser

Info

Publication number
DK0772450T3
DK0772450T3 DK95917218T DK95917218T DK0772450T3 DK 0772450 T3 DK0772450 T3 DK 0772450T3 DK 95917218 T DK95917218 T DK 95917218T DK 95917218 T DK95917218 T DK 95917218T DK 0772450 T3 DK0772450 T3 DK 0772450T3
Authority
DK
Denmark
Prior art keywords
methods
treating
vwd
bleeding disorders
von willebrand
Prior art date
Application number
DK95917218T
Other languages
English (en)
Inventor
James A Kaye
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Application granted granted Critical
Publication of DK0772450T3 publication Critical patent/DK0772450T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2073—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK95917218T 1994-07-22 1995-04-27 Fremgangsmåder til behandling af blødningsforstyrelser DK0772450T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/278,765 US5582821A (en) 1994-07-22 1994-07-22 Methods for treating bleeding disorders
PCT/US1995/005439 WO1996003143A1 (en) 1994-07-22 1995-04-27 Methods for treating bleeding disorders

Publications (1)

Publication Number Publication Date
DK0772450T3 true DK0772450T3 (da) 2003-04-14

Family

ID=23066267

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95917218T DK0772450T3 (da) 1994-07-22 1995-04-27 Fremgangsmåder til behandling af blødningsforstyrelser

Country Status (10)

Country Link
US (1) US5582821A (da)
EP (1) EP0772450B1 (da)
JP (1) JPH10503195A (da)
AT (1) ATE219372T1 (da)
AU (1) AU2381795A (da)
DE (1) DE69527145T2 (da)
DK (1) DK0772450T3 (da)
ES (1) ES2177646T3 (da)
PT (1) PT772450E (da)
WO (1) WO1996003143A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO439396A0 (en) 1996-12-24 1997-01-23 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
US6953777B2 (en) 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
NZ516664A (en) * 1999-07-15 2003-06-30 Inst Genetics Llc Formulations and compositions for interleukin-11
AU2002362088A1 (en) * 2001-12-06 2003-06-23 Catholic University Method and composition for inducing weight loss
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
AU2012255137A1 (en) 2011-05-17 2013-12-12 The Brigham And Women's Hospital, Inc. Improved platelet storage using a sialidase inhibitor
EP2903430A1 (en) 2012-10-05 2015-08-12 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor
WO2014120886A1 (en) 2013-01-30 2014-08-07 Velico Medical, Inc. Platelet additive solution having a self-assembling hydrogel-forming peptide
US20150160214A1 (en) * 2013-12-05 2015-06-11 Mayo Foundation For Medical Education And Research Quantitation of Cellular Adhesion Dynamics Across Immobilized Receptors Under Rheological Shear Flow
CA3211686A1 (en) 2021-02-26 2022-09-01 Bayer Aktiengesellschaft Inhibitors of il-11 or il-11ra for use in the treatment of abnormal uterine bleeding

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
DK0546124T4 (da) * 1990-08-29 2003-05-19 Inst Genetics Llc Hæmatopoiese-stimulatorer med flere domæner
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5292646A (en) * 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
EP0560998A4 (en) * 1991-10-09 1993-12-01 Toray Industries, Inc. Medicine for preventing and treating bleeding tendency

Also Published As

Publication number Publication date
US5582821A (en) 1996-12-10
EP0772450B1 (en) 2002-06-19
EP0772450A1 (en) 1997-05-14
JPH10503195A (ja) 1998-03-24
PT772450E (pt) 2002-10-31
ES2177646T3 (es) 2002-12-16
DE69527145T2 (de) 2003-02-13
WO1996003143A1 (en) 1996-02-08
ATE219372T1 (de) 2002-07-15
DE69527145D1 (de) 2002-07-25
AU2381795A (en) 1996-02-22

Similar Documents

Publication Publication Date Title
ES2037664T3 (es) Composiciones y metodos para el tratamiento de trastornos hemorragicos.
DE69521623D1 (de) Zusammensetzung für die stabilisation von zahnprothesen
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE59407237D1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
ATE88899T1 (de) Wundheilung und knochenregeneration.
ES2115679T3 (es) Preparacion de reactivos de tiempo de protrombina a partir de factor de tejido humano recombinante y de fosfolipidos sinteticos y naturales purificados.
MX9603285A (es) Concentrado de plasma y composiciones obturadoras de tejido y metodos y aparatos para preparar el concentrado de plasma y/o el obturador de tejido para sellar el tejido, para la separacion rapida de particulas de suspensiones y para la concentracion
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
DK0719154T3 (da) Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
HUP9903336A2 (hu) Szulfonsav-N-[(amino-imino-metil)-fenil]-aza-heretero-ciklil-amid származékok és az ezeket tartalmazó gyógyszerkészítmények
PT772450E (pt) Metodos para tratar disturbios hemorragicos
DE3751179D1 (de) Peptide, die die Bindung des Von-Willebrand-Faktors inhibieren.
NO995843D0 (no) Farmasöytisk preparat omfattende vWF-propeptid
ES2173858T3 (es) Analogos de huperzina a.
ATE25690T1 (de) Gerinnungsaktive plasmaproteinloesung, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von stoerungen des haemostasesystems.
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
DE3482800D1 (de) Herstellung von nadelkoks.
DE69433875D1 (de) Verfahren zur präparation von humanem aktiviertem protein c
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
US4191751A (en) Method for promoting growth of new connective tissue over surface wounds
ATE430578T1 (de) Faktor viii oder von willebrand faktor zur behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen
DK59785A (da) Fremgangsmaade til fremstilling af i det vaesentlige fibrinogenfrit ahf
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
Holman Experimental Necrotizing Arteritis in Dogs: III. Bilateral Nephrectomy as Effective as Heavy Metal Injury in its Production